CBD gel tested to calm anxiety in kids with rare genetic disorder
NCT ID NCT05149898
Summary
This study tested whether a cannabidiol (CBD) gel applied to the skin is safe and helpful for children and teenagers with 22q11.2 deletion syndrome. The goal was to see if the gel could ease anxiety and improve difficult behaviors. About 20 participants, aged 4 to 18, used the gel for up to 38 weeks while doctors tracked their symptoms and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 22Q11.2 DELETION SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Genetics Clinics Australia
Melbourne, Victoria, 3161, Australia
-
Greenwood Genetic Center
Greenville, South Carolina, 29605, United States
-
Lady Cilento Children's Hospital - South Brisbane
Brisbane, Queensland, 4101, Australia
Conditions
Explore the condition pages connected to this study.